Dosis 1/2018
Farmaseuttinen aikakauskirja DOSIS 1/2018 vol.43 Suomen Farmasialiitto ry
Farmaseuttinen aikakauskirja DOSIS 1/2018 vol.43 Suomen Farmasialiitto ry
- No tags were found...
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
Raynor DK: User testing in developing patient<br />
medication information in Europe. Res Social<br />
Adm Pharm 9 (5): 640-645, 2013<br />
Rutter P, Newby D: Community pharmacy: symptoms,<br />
diagnosis and treatment. 2nd ed. Sydney,<br />
NSW: Churchill Livingstone, 2011<br />
Tong V: Optimising written information for overthe-counter<br />
medicines. Doctor of Philosophy dissertation.<br />
Sydney, NSW: The University of Sydney,<br />
2016<br />
Trajanovska M, Manias E, Cranswick N, Johnston<br />
L: Parental management of childhood complaints:<br />
over-the-counter medicine use and advice-seeking<br />
behaviours. J Clin Nurs 19 (13-14): 2065-2075, 2010<br />
Appendix 1. Relevant core semi-structured interview questions<br />
Protocol section<br />
Perspectives<br />
on the label<br />
Core question(s)<br />
1. Firstly, what are your overall thoughts about the box/product packaging, in<br />
terms of how easy/hard it is to read and the information that is included on it?<br />
2. Looking at the information that is written on the box/product packaging, what<br />
do you think about the amount of information that it contains?<br />
3. What do you think about the layout of the information on the box?<br />
4. Thinking back to how you used the box/product packaging to answer the<br />
questions before, what information was easy or difficult to find and/or<br />
understand?<br />
Improvement(s)<br />
needed to the<br />
label<br />
5. From your point of view, how can we improve the information on the box<br />
in the future to improve its readability and how well it is understood?<br />
Perspectives on<br />
the leaflet<br />
6. What are your overall thoughts about the leaflet?<br />
7. Thinking back to how you used the leaflet when answering the questions<br />
earlier, what information was easy or difficult to find and/or understand<br />
in the leaflet?<br />
Perspectives on<br />
leaflet availability<br />
8. The leaflet that you helped us test today is not actually available inside the<br />
pack. We developed the leaflet for the purposes of the study. Benadryl®<br />
Dry, Tickly Cough does not come with a leaflet. What do you think about this<br />
medicine not having a leaflet?<br />
Improvement(s)<br />
needed to the<br />
leaflet<br />
9. From your point of view, how can we make this leaflet better in the future?<br />
© Suomen Farmasialiitto ry 31<br />
© DOSIS nr0 1/<strong>2018</strong>
Change language